These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27699426)

  • 1. Psychotropic Alternatives to Antipsychotic Medications in Treating Dementia Behaviors: An Evidence-Based Practice Protocol.
    Birtley NM
    J Psychosoc Nurs Ment Health Serv; 2016 Oct; 54(10):46-53. PubMed ID: 27699426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacological medication use among older adults with dementia in nursing homes.
    Brandt NJ; Pythtila J
    J Gerontol Nurs; 2013 Apr; 39(4):8-14. PubMed ID: 23616986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes.
    Gerlach LB; Maust DT; Kales HC; Chang M; Kim HM; Wiechers IR; Zivin K
    Am J Psychiatry; 2022 Aug; 179(8):544-552. PubMed ID: 35615813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes.
    Ellis ML; Molinari V; Dobbs D; Smith K; Hyer K
    Aging Ment Health; 2015; 19(6):507-16. PubMed ID: 25166458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving antipsychotic agent use in nursing homes: development of an algorithm for treating problem behaviors in dementia.
    Smith M; Schultz SK; Seydel LL; Reist J; Kelly M; Weckmann M; Gryzlak B; Carnahan R
    J Gerontol Nurs; 2013 May; 39(5):24-35; quiz 36-7. PubMed ID: 23506127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Antipsychotic Medications: Developing a Systematic Process.
    McHenry Martin C
    Consult Pharm; 2015 Jul; 30(7):378-84. PubMed ID: 26173189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationales that providers and family members cited for the use of antipsychotic medications in nursing home residents with dementia.
    Bonner AF; Field TS; Lemay CA; Mazor KM; Andersen DA; Compher CJ; Tjia J; Gurwitz JH
    J Am Geriatr Soc; 2015 Feb; 63(2):302-8. PubMed ID: 25643635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences on Decision-Making Regarding Antipsychotic Prescribing in Nursing Home Residents With Dementia: A Systematic Review and Synthesis of Qualitative Evidence.
    Walsh KA; Dennehy R; Sinnott C; Browne J; Byrne S; McSharry J; Coughlan E; Timmons S
    J Am Med Dir Assoc; 2017 Oct; 18(10):897.e1-897.e12. PubMed ID: 28807433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in antipsychotic treatment choice across US nursing homes.
    Huybrechts KF; Rothman KJ; Brookhart MA; Silliman RA; Crystal S; Gerhard T; Schneeweiss S
    J Clin Psychopharmacol; 2012 Feb; 32(1):11-7. PubMed ID: 22198446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partnership to decrease antipsychotic medication use in nursing homes: impact at the state level.
    Mort JR; Sailor R; Hintz L
    S D Med; 2014 Feb; 67(2):67-9. PubMed ID: 24624602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic prescribing in nursing homes: an audit report.
    Morrison A
    Qual Prim Care; 2009; 17(5):359-62. PubMed ID: 20003722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic prescribing patterns in a Medicare Advantage population of older individuals with dementia.
    Kester R; Unützer J; Hogan D; Huang H
    J Ment Health; 2017 Apr; 26(2):167-171. PubMed ID: 27841049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review.
    Thompson Coon J; Abbott R; Rogers M; Whear R; Pearson S; Lang I; Cartmell N; Stein K
    J Am Med Dir Assoc; 2014 Oct; 15(10):706-18. PubMed ID: 25112229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Off-Label Antipsychotic Medication Use in a Randomly Selected Nursing Home Sample Based on Resident and Facility Characteristics.
    Mansbach WE; Mace RA; Clark KM; Firth IM; Breeden JK
    Res Gerontol Nurs; 2016 Nov; 9(6):257-266. PubMed ID: 27665755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
    Wightman R; Fielding J; Green S
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMS seeks to reduce antipsychotic use in nursing home residents with dementia.
    Mitka M
    JAMA; 2012 Jul; 308(2):119, 121. PubMed ID: 22782393
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish context.
    Karlsson S; Rahm Hallberg I; Midlöv P; Fagerström C
    BMC Psychiatry; 2017 Jul; 17(1):251. PubMed ID: 28705243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.